Nest Health Tech Analysis: $15M Raised
What is Nest Health Tech?
Nest Genomics describes itself as an AI-native genomics platform for identifying, testing, and managing patients at scale. The company says its software supports genomic programs through patient identification, smart ordering, results ingestion, and clinical decision support inside existing clinical workflows. It is backed by Y Combinator and claims HIPAA compliance, SOC 2 Type II, and integrations with several major EHR and data platforms.
Location
9450 South West Gemini Drive, Beaverton, Oregon 97008, United States
Employees
11-50
Founded
2022
Revenue
<$5M
Product Features & Capabilities
- One platform for genomic programs, patient identification, Clinical Decision Support, tailored educational resources, HIPAA & SOC 2 certified, EMR integration, robust analytics, coordinated genomic care, modular design for workflows, evidence-based development with genetics experts.
How much Nest Health Tech raised
1 - $15 million
March 2023Lead Investor: B Capital
Who are the founders of Nest Health Tech
MS
Moran Snir
Founder
GS
Guy Snir
Founder/COO
Business Model
Revenue generated through partnerships with healthcare organizations and health insurance providers.
Market Focus
Nest Health Tech primarily focuses on the healthcare industry, specifically in the field of genomics and genetic testing. They provide a software platform that facilitates the implementation of genetics at the point of care within healthcare organizations.
Competitors Overview
Nest Health Tech operates in the genomics and healthcare technology sector, focusing on simplifying the implementation of genetics in healthcare settings. Its main competitors include:
-
GenoTwin:
- Overview: GenoTwin is a next-generation genomics platform that combines genomics expertise with data science. It focuses on transforming the detection of pathogens and assessing immune responses, which is crucial for public health.
- Advantages: GenoTwin's integration of data science with genomics allows for advanced diagnostics and surveillance of pathogens, potentially offering more comprehensive solutions in infectious disease management compared to Nest Health Tech's focus on point-of-care genetic implementation.
-
Stratenym:
- Overview: While specific details about Stratenym were not retrieved, it is known to operate within the genomics and healthcare technology space, likely offering solutions that may overlap with Nest Health Tech's offerings.
- Advantages: Competitors like Stratenym may provide unique features or services that cater to specific niches within the healthcare genomics market, which could differentiate them from Nest Health Tech.
These competitors highlight the diverse approaches within the genomics sector, with GenoTwin emphasizing pathogen detection and Stratenym potentially focusing on other specialized genomic applications.
Investors
- 10X Capital
- 8VC
- Alumni Ventures
- Blue Venture Fund
- Gaingels
- Ochsner Ventures
- SpringTide
- B Capital
- Arkin Holdings
- Casdin Capital
See something that needs updating? Suggest edits to this profile.